Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Impact of Earplugs on Mechanisms of Noise-Related Cardiovascular Disease

for
Cardiometabolic Diseases, Noise Exposure
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 65

Code: NCT07148817

Recruiting

Self-regulation of Real-time fMRI Brain Activity in Chronic Pain

for
Fibromyalgia
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 65

Code: NCT07023523

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Boston MA, Providence RI, Worcester MA, Springfield MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Boston MA, Burlington MA, Springfield MA, Hartford CT,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase2, Recruiting

Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)

for
Heart Failure
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70+

Code: NCT07337577

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efgartigimod for the Treatment of Acute Optic Neuritis

for
Optic Neuritis
Location: Boston MA
Sponsor: Anastasia Vishnevetsky, MD, MPH

Sex: All

Age: 18+

Code: NCT06453694

Phase2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Boston MA, Commack NY, Harrison NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase2, Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

for
Advanced Lung Neuroendocrine Tumor,
Location: Boston MA, Philadelphia PA, Pittsburgh PA, Cleveland OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04665739

Phase2, Recruiting

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

for
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Location: Boston MA, New York NY, Hackensack NJ, Rochester NY,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 8+

Code: NCT06098430

Recruiting

Pembro Plus CAR T-cell Therapy in R/R in PMBCL

for
Primary Mediastinal Large B-cell Lymphoma (PMBCL),
Location: Boston MA, New York NY
Sponsor: Jennifer Crombie, MD

Sex: All

Age: 18+

Code: NCT05934448

Phase2, Recruiting

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Location: Boston MA, Philadelphia PA, Montreal,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 21

Code: NCT04655404

Early_phase1, Recruiting

IS-free Treg HaploHCT

for
Stem Cell Transplant Complications, Graft Vs Host Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT04678401

Phase1, Recruiting

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05372640

Phase1, Recruiting

Lurbinectedin in FET-Fused Tumors

for
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor,
Location: Boston MA, New York NY, Philadelphia PA, Ann Arbor MI,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10+

Code: NCT05918640

Phase1, Phase2, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Burlington MA, Westbrook ME, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase3, Recruiting

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

for
Prostate Cancer (Adenocarcinoma), Prostate Specific Antigen
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 18+

Code: NCT06862856

Recruiting

A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser

for
Healthy
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06295471

Recruiting

EVOC - EVs in Obesity and Cardiometabolic Disease

for
Cardiovascular Diseases
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06408961

Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

for
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer,
Location: Boston MA, New York NY, Richmond VA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT03564340

Phase1, Phase2, Recruiting

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Hillsborough NC, Nashville TN,
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT06375044

Phase1, Recruiting